ARCTURUS THERAPEUTICS HOLDINGS INC. Restricted Cash, Current
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Restricted Cash, Current of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-06
- 2026-06-30: Restricted Cash, Current $0.00.
- 2026-03-31: Restricted Cash, Current $0.00.
- 2025-09-30: Restricted Cash, Current $55.00M.
- 2025-06-30: Restricted Cash, Current $55.00M.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-09-30 | $55.00M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $55.00M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $38.50M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $55.00M 10-K · filed 2026-03-03 |
| 2024-09-30 | $55.00M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $55.00M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $55.00M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $55.00M 10-K · filed 2026-03-03 |
| 2023-09-30 | $35.00M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $55.00M 10-Q · filed 2024-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |